Le Lézard
Classified in: Health
Subjects: TDS, FVT

Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference


DUBLIN, Nov. 22, 2019 /CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida on Tuesday, December 3, 2019 at 8:50 a.m. ET.

A live webcast and audio archive for the event will be available on the Company's website at http://investor.endo.com/events-and-presentations. Participants should allow approximately 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. 

About Endo International plc

Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

 

SOURCE Endo International plc


These press releases may also interest you

at 03:00
Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, today announces signing of a License and Collaboration Agreement with Novartis. The joint research collaboration is aimed at the identification...

at 03:00
U.S. Dermatology Partners is proud to announce 6 dermatologists from the Maryland and Virginia region have been named Washingtonian's Top Docs in the field of Dermatology. Each spring, The Washingtonian asks close to 13,000 doctors in DC, Maryland,...

at 03:00
NDA Partners Chairman Carl Peck, MD, announced today that Diane Jorkasky, MD, FACP, an internationally recognized clinical pharmacologist, drug development scientist, and healthcare executive with global medical and scientific leadership experience...

at 02:57
BioInvent International AB (publ) (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris: TNG), a biotech company that...

at 02:46
Nanjing Jiangbei New Area, a state-level new area in East China's Jiangsu Province, is committed to building a 100 billion-yuan level life and health industrial cluster and becoming a gene city in China. The news was announced by Luo Qun, a member of...

at 02:20
Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (OMXS: BINV), a biotech company focused on the discovery and development of...



News published on 22 november 2019 at 17:00 and distributed by: